Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Top Performing Leveraged/Inverse ETFs: 12/01/2024

BY | ETF Database
8:55 am ET 12/04/24 | 36 VIEWS
Top Performing Levered/Inverse ETFs Last WeekThese were last week’s top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly. Always do your homework.1. ETHU – 2x Ether ETF ETHU ETF, which aims to provide 2x the daily price movements of Ether, topped the leveraged ETFs list with ~17% weekly gains. Ether ETFs have surged in popularity following Trump’s pledge to ease crypto regulations. Ether ETFs are experiencing record daily subscriptions, indicating growing investor interest. 2. ETHT – ProShares Ultra Ether ETF ETHT, which tracks twice the daily price movements of an index that measures the price of Ether, ranked second on the list. The price of ether hit a high, driven by positive regulatory expectations under the new Trump administration and strong inflows into Ether ETFs. 3. BZQ – ProShares Ultrashort MSCI Brazil Capped ETF The BZQ ETF offers a good way to play the bearish short-term outlook for Brazilian large-cap stocks. This inverse ETF returned more than 14% in the last week. Brazil’s market decline is part of a broader sell-off in emerging markets, driven by Donald Trump’s election, and expectations of rising global interest rates and a stronger US dollar. 4. TMF – Direxion Daily 20+ Year Treasury Bull 3X Shares Direxion Daily 20+ Year Treasury Bull 3X Shares, which tracks the NYSE 20 Year Plus Treasury Bond Index, was also on the list of top-performing levered/ inverse ETFs. US 10-year Treasury yields fell to a two-week low as bond prices rallied following Bessent’s appointment. 5. AMZU – Direxion Daily AMZN Bull 1.5X Shares ETF AMZU provides 1.5x leveraged exposure to the daily price movement for shares of Amazon stock with ~11% weekly gains. Amazon’s stock rose as analysts believe a shorter holiday shopping season could benefit the tech giant. 6. LABU – Direxion Daily S&P Biotech Bull 3x Shares The biotech fund, LABU, gained over 10% and was one of the top-performing levered ETFs on the list last week as the biotech sector gained by ~0.05%. Robert F. Kennedy Jr.’s openness to using psychedelics in therapeutic settings has led to a surge in biotech stocks focused on psychedelic research. 7. BABX – GraniteShares 1.75x Long BABA Daily ETF BABX, which provides 1.75x leveraged exposure to the daily price movement for shares of Alibaba Group Holding Limited stock, was one of the leveraged ETFs making the list with over ~10% weekly gains. Alibaba’s stock surged, buoyed by a strong earnings report following the company’s announcement of a new suite of open-source AI models and text-to-video AI technology. 8. NAIL – Direxion Daily Homebuilders & Supplies Bull 3X Shares The NAIL ETF, which focuses on the US housing segment, was one of the contenders on the list of top-performing levered ETFs returning over ~8% amid declining Treasury yields. This could potentially lead to lower mortgage rates following President-elect Donald Trump’s selection of hedge fund manager Bessent for the Treasury secretary position. 9. EVAV – Direxion Daily Electric and Autonomous Vehicles Bull 2X Shares EVAV, which tracks 2x the daily price movements of an index of US-listed electric and autonomous vehicles companies, was another contender on the list of top-performing levered ETFs as the electric vehicle sector is experiencing a boom, as the incoming Trump administration with Tesla CEO Elon Musk playing a key role, is expected to facilitate Tesla’s pursuit of self-driving cars and AI. 10. MSOX – AdvisorShares MSOS 2x Daily ETF MSOX, which seeks to achieve 2x the total daily return of the AdvisorShares Pure US Cannabis ETF (MSOS) through swap agreements, topped the list with a ~7% weekly return. US cannabis companies are experiencing a surge in optimism with Trump’s second term, his recent support for state-level legalization, and his nomination of pro-cannabis appointments. For more news, information, and analysis, visit the Leveraged & Inverse Channel.

More Commentary

This Sector Is a Major AI Adopter
BY | ETF Database
5:50 am ET 12/04/24 | 104 VIEWS
Bitcoin Boom Boosts This ETF
BY | ETF Database
5:16 am ET 12/04/24 | 116 VIEWS
High-Yield Prospects: December 4 Edition
BY | ETF Database
9:39 am ET 12/04/24 | 19 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.